---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-029659"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2023-06-23T23:59:59+00:00"
generated_at: "2026-06-13T17:55:01.521938+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Heart Test receives Nasdaq delisting notice for equity non-compliance; plans appeal

## Summary
- Received delist determination on June 20, 2023 for failing to meet $2.5M stockholders' equity by June 19 deadline.
- Intends to appeal to Nasdaq Hearings Panel, which stays delisting pending hearing process.
- Stock (HSCS) and warrants (HSCSW) continue trading on Nasdaq pending hearing outcome; no guarantee of extension.
- Previously granted extension until June 19, 2023, but failed to comply.

## SEC filing metadata
- accession: 0000950170-23-029659
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2023-06-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017023029659/0000950170-23-029659-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017023029659/hscs-20230620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-029659
- JSON: https://secwatch.observer/filing/0000950170-23-029659.json
- Plain text: https://secwatch.observer/filing/0000950170-23-029659.txt

## Key facts
- Listing & Compliance Notices
  HeartSciences Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)
  source text: June 20, 2023, the Company received a delist determination letter from the Staff advising the Company that the Staff had determined that the Company did not meet the terms of the extension by the June 19, 2023 deadline. The Company intends to timely appeal the Staff's delisting determination by submitting a hearing request to the Nasdaq Hearings Panel (the “Panel”), which request will automatically stay the delisting of the Company's securities by the Staff at least until the hearing process concludes and any extension granted by the Panel expires. At the Panel hearing, the Company intends to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468492/000095017023029659/0000950170-23-029659-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.